Results 171 to 180 of about 57,926 (263)

The Effect of Dicloxacillin Administration on Pharmacokinetics of Narrow Therapeutic Window Drugs: Phenytoin and Warfarin

Clinical Pharmacology &Therapeutics, EarlyView.
Dicloxacillin is a penicillinase‐resistant beta‐lactam antibiotic and potent activator of the Pregnane X receptor (PXR), known to induce CYP2C9, CYP2C19, and CYP3A4 activity. Clinical data suggest it reduces anticoagulation in warfarin‐treated patients and increases the risk of thromboembolic events.
Chanan Shaul, Waseem Mujahed, Ibrahim Idries, Maor Wanounou, Meir Bialer, Yoseph Caraco   +5 more
wiley   +1 more source

Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE^® (TrenibotE). [PDF]

Toxins (Basel)
Yang Y, Zhang H, Wang S, Xue Y, Yuan L.
europepmc   +1 more source

Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Accurate quantification of chimeric antigen receptor (CAR) T cells is essential for monitoring post‐infusion CART expansion and persistence and for real‐time clinical decision‐making. Multiparameter flow cytometry (MFC) enables rapid, live‐cell detection with absolute quantification and concurrent immunophenotypic characterization. This review
Jianhua Ling, Wei Wang, Sa A. Wang
wiley   +1 more source

Response by Chirumbolo to "Rare Localized Adverse Reaction to Botulinum Toxin Type A in a Patient Without Allergic History: A Case Report" by Muner et al. [PDF]

Aesthet Surg J Open Forum
Chirumbolo S.
europepmc   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

Resistance to cosmetic botulinum toxin A: A 15-patient case series across 12 sites

JAAD International
Carlos G. Wambier, MD, PhD, Fatima N. Mirza, MD, MPH, Sarah P.F. Wambier, MD, PhD, Vince Bertucci, MD, Jean Carruthers, MD, Joely Kaufman, MD, John Martin, MD, J. Barton Sterling, MD, Flávia Brasileiro, MD, Carolina Marçon, MD, MSc, Allison J. Brown, MD, Miranda Rosenberg, MD, Lilia R.S. Guadanhim, MD, PhD, Doris Hexsel, MD   +13 more
doaj   +1 more source

Dysphagia After Cosmetic Submandibular Gland Botulinum Neurotoxin Type A Injection: A Case Report. [PDF]

Healthcare (Basel)
Yang S, Yi YG.
europepmc   +1 more source

Waiting time to see a dermatologist in South Africa: A cross-sectional survey. [PDF]

J Coll Med S Afr
de Jager RS, Gray NA, Visser WI.
europepmc   +1 more source

Serum methylmalonic acid levels and epilepsy prevalence: Association analysis, exploratory mediation, and clinical corroboration

Epileptic Disorders, EarlyView.
Abstract Objective This study aimed to investigate the association between methylmalonic acid (MMA) and epilepsy prevalence and to explore potential inflammatory and nutritional pathways underlying this association. Methods This study included adults aged ≥ 20 years from the National Health and Nutrition Examination Survey (NHANES) 2011–2014.
Ningyu Wei, Ning Huang, Haipeng Chen, Rui Tang, Yuan Cheng, Xiang Zhang   +5 more
wiley   +1 more source

Improved Extraction of the Neurotoxin of <i>Stenocarpella maydis</i> Using an Artificial Rumen. [PDF]

Vet Med Int
Snyman LD.
europepmc   +1 more source